Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGPhase 4INTERVENTIONAL

Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.

Who May Be Eligible (Plain English)

Who May Qualify: - Status as HIV+ - Age 18 or older - Currently smokes ≥ 5 CPD, on average, in past month - Positive for salivary cotinine - Able to understand the nature of the study and the consenting process - Is engaged in HIV clinical care - Living in larger NYC metropolitan area currently and for the next 6-8 months Who Should NOT Join This Trial: - Suffers from any medical condition or contraindication precluding use of nicotine replacement therapy - Current use of any tobacco cessation medications (varenicline, NRT patch, nicotine gum, lozenge, spray or inhaler, or bupropion) - Currently participating in a smoking cessation program - Pregnant or nursing and plans to be in next 6 months - Has schizophrenia/schizo-affective disorder - Does not have a functioning mobile phone that can receive text messages Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Status as HIV+ * Age 18 or older * Currently smokes ≥ 5 CPD, on average, in past month * Positive for salivary cotinine * Able to understand the nature of the study and the consenting process * Is engaged in HIV clinical care * Living in larger NYC metropolitan area currently and for the next 6-8 months Exclusion Criteria: * Suffers from any medical condition or contraindication precluding use of nicotine replacement therapy * Current use of any tobacco cessation medications (varenicline, NRT patch, nicotine gum, lozenge, spray or inhaler, or bupropion) * Currently participating in a smoking cessation program * Pregnant or nursing and plans to be in next 6 months * Has schizophrenia/schizo-affective disorder * Does not have a functioning mobile phone that can receive text messages

Treatments Being Tested

BEHAVIORAL

Motivational Interviewing (MI) Counseling

Six sessions of phone counseling over 10-12 weeks with MI counselor trained in motivational interviewing and tobacco use treatment.

BEHAVIORAL

Peer Mentoring

Eight sessions of informal counseling with an experienced peer former smoker living with HIV to model healthy behavior and provide practical advice and tips for quitting based on their lived experience.

BEHAVIORAL

Skills-based Text Messaging

NCI's 8-week text messaging smoking cessation program, smokefreeTXT.gov.

DRUG

Combination NRT

If they smoke 10 or more cigarettes per day (CPD), participants will receive 2 weeks of 21 mg patches, 2 weeks of 14 mg patches and 2 weeks of 7 mg patches; if they smoke less than 10 CPD, participants will receive 4 weeks of 14 mg patches and 2 weeks of 7 mg patches. Participants will receive either 2 or 4 mg of nicotine lozenges for a total of up to 20 lozenges per day.

Locations (1)

New York University School of Global Public Health
New York, New York, United States